RDiscovery’s team includes experienced professionals with deep expertise in the life sciences, biomedical industry, business, finance, and law. Our community thrives by championing collaboration, diversity, and unity.
© Copyright 2023 | RDiscovery | All Rights Reserved
Taro is Founder and Managing Partner at Remiges Ventures. He has over 31 years of business experience including 21 years in start-up financing and company creation in the life science area. At Remiges, Taro is engaged in technology sourcing, company creation, leading negotiation for investments and serving as director for the Remiges’ portfolio companies including Inflectis, Omeicos, Imel and Tranquis. Prior to establishing Remiges, Taro managed the biopharma investment team and investment portfolio at divisions of Mitsui & Co., Ltd. Taro holds a B.E. in Polymer Chemistry, Kyoto University and MBA from European University.
Taka has over 20 years of business development and venture investment experience. At Remiges, Taka is engaged in technology sourcing, company creation, leading negotiation for investments, and serving as director for the Remiges’ portfolio companies including Digestome, Cyrano and Immunis, and as president of Digestome Japan. During his tenure at Mitsui, he held several positions as a board member, in acting management roles in newly created companies, and raising capital at globally diversified portfolio companies. Taka holds a BS in Engineering from the University of Tokyo.
Aki has more than 20 years of experience in search and evaluation, business development and venture investment. At Remiges, Aki is engaged in technology sourcing, leading negotiation for investments and serving as director for the Remiges’ portfolio companies including KisoJi, Phost’In and Qinotto. Prior to joining Remiges, he was at Ora as Vice President of Corporate Development. Aki worked at Daiichi-Sankyo for more than 13 years with focusing on identifying opportunities from discovery to late clinical stage. Aki holds a BSc. in Material Sciences from Tokyo Univ. of Agriculture and Technology, MSc. from San Diego State University and M.B.A. from the UCSD.
Hans is an internationally known stem cell expert and serial entrepreneur who has led therapy development for cancer, spinal cord injury, immune disorders, motor neuron disease, retinal disease, and infectious disease. He has founded 5 successful biotechnology companies. He and his teams have led 17 successful clinical trials. Previously, he was Professor of Anatomy and Neurobiology at the University of California, Irvine, where he co-founded and directed the $77 million Sue and Bill Gross Stem Cell Research Center. He was a founding advisor of the California stem cell initiative that resulted in the $8.5 billion CIRM stem cell fund and has been a long-time advisor to several governments on biomedical policy.
Kazu has over 20 years of experience in drug discovery, licensing, and search and evaluation. At Remiges, Kazu is engaged in technology sourcing, company creation, leading negotiation for investments and serving as director for the Remiges’ portfolio companies including Kupando and Restore Vision. Prior to joining Remiges, he worked at Nippon Boheringer Ingelheim for search and evaluation of Japanese innovative seeds. Kazu holds MSc from graduate school of agriculture in Kyoto University and PhD from graduate school of medical sciences in Nagoya City University.
